Literature DB >> 3162766

Correction of mouse ornithine transcarbamylase deficiency by gene transfer into the germ line.

C Cavard1, G Grimber, N Dubois, J F Chasse, M Bennoun, M Minet-Thuriaux, P Kamoun, P Briand.   

Abstract

The sparse fur with abnormal skin and hair (Spf-ash) mouse is a model for the human X-linked hereditary disorder, ornithine transcarbamylase (OTC) deficiency. In Spf-ash mice, both OTC mRNA and enzyme activity are 5% of control values resulting in hyperammonemia, pronounced orotic aciduria and an abnormal phenotype characterized by growth retardation and sparse fur. Using microinjection, we introduced a construction containing rat OTC cDNA linked to the SV40 early promoter into fertilized eggs of Spf-ash mice. The expression of the transgene resulted in the development of a transgenic mouse whose phenotype and orotic acid excretion are fully normalized. Thus, the possibility of correcting hereditary enzymatic defect by gene transfer of heterologous cDNA coding for the normal enzyme has been demonstrated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3162766      PMCID: PMC338202          DOI: 10.1093/nar/16.5.2099

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  23 in total

1.  Abnormal ornithine carbamoyltransferase in mice having the sparse-fur mutation.

Authors:  R DeMars; S L LeVan; B L Trend; L B Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

2.  The molecular basis of the sparse fur mouse mutation.

Authors:  G Veres; R A Gibbs; S E Scherer; C T Caskey
Journal:  Science       Date:  1987-07-24       Impact factor: 47.728

3.  A new allele of the sparse fur gene in the mouse.

Authors:  D P Doolittle; L L Hulbert; C Cordy
Journal:  J Hered       Date:  1974 May-Jun       Impact factor: 2.645

4.  The effects of pH on the kinetics of human liver Ornithine--carbamyl phosphate transferase.

Authors:  P J Snodgrass
Journal:  Biochemistry       Date:  1968-09       Impact factor: 3.162

5.  Cell-free synthesis and transport of precursors of mutant ornithine carbamoyltransferases into mitochondria.

Authors:  P Briand; S Miura; M Mori; L Cathelineau; P Kamoun; M Tatibana
Journal:  Biochim Biophys Acta       Date:  1983-11-08

6.  Transmission distortion and mosaicism in an unusual transgenic mouse pedigree.

Authors:  R D Palmiter; T M Wilkie; H Y Chen; R L Brinster
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

7.  Increase of ornithine transcarbamylase protein in sparse-fur mice with ornithine transcarbamylase deficiency.

Authors:  P Briand; L Cathelineau; P Kamoun; D Gigot; M Penninckx
Journal:  FEBS Lett       Date:  1981-07-20       Impact factor: 4.124

8.  Gene transfer into mouse embryos: production of transgenic mice by pronuclear injection.

Authors:  J W Gordon; F H Ruddle
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

9.  Citrulline synthesis in rat tissues and liver content of carbamoyl phosphate and ornithine.

Authors:  L Raijman
Journal:  Biochem J       Date:  1974-02       Impact factor: 3.857

10.  Prenatal lethalities in mice homozygous for human growth hormone gene sequences integrated in the germ line.

Authors:  E F Wagner; L Covarrubias; T A Stewart; B Mintz
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

View more
  6 in total

1.  Simultaneous detection of mutant gene and transgene in ornithine carbamoyl-transferase-deficient spf-ash mice with rat OCT gene.

Authors:  K Kobayashi; M Horiuchi; A Yokokouji; T Shimada; T Saheki
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  The human pH aldolase A promoter directs widespread but muscle-predominant expression in transgenic mice.

Authors:  C Moch; F Spitz; A Porteu; A Kahn; D Daegelen
Journal:  Transgenic Res       Date:  1998-03       Impact factor: 2.788

3.  The spfash mouse: a missense mutation in the ornithine transcarbamylase gene also causes aberrant mRNA splicing.

Authors:  P E Hodges; L E Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

Review 4.  Contrasting features of urea cycle disorders in human patients and knockout mouse models.

Authors:  Joshua L Deignan; Stephen D Cederbaum; Wayne W Grody
Journal:  Mol Genet Metab       Date:  2007-10-22       Impact factor: 4.797

5.  Functional characterization of the spf/ash splicing variation in OTC deficiency of mice and man.

Authors:  Ana Rivera-Barahona; Rocío Sánchez-Alcudia; Hiu Man Viecelli; Veronique Rüfenacht; Belén Pérez; Magdalena Ugarte; Johannes Häberle; Beat Thöny; Lourdes Ruiz Desviat
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

6.  Long-term effects of medical management on growth and weight in individuals with urea cycle disorders.

Authors:  Roland Posset; Sven F Garbade; Florian Gleich; Andrea L Gropman; Pascale de Lonlay; Georg F Hoffmann; Angeles Garcia-Cazorla; Sandesh C S Nagamani; Matthias R Baumgartner; Andreas Schulze; Dries Dobbelaere; Marc Yudkoff; Stefan Kölker; Matthias Zielonka
Journal:  Sci Rep       Date:  2020-07-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.